Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Liska

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Diseases of the Colon and Rectum|December 9, 2021
Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch SyndromeHanumant Chouhan, Mohammad Ali Abbass, Jennifer E Hrabe, et al.
Diseases of the Colon and Rectum|November 11, 2024
Is Early, Postinduction Restaging of Rectal Cancer Undergoing Total Neoadjuvant Therapy Associated With Ultimate Treatment Response?William C Chapman, Emre Gorgun, Sumeyye Yilmaz, et al.
Neoplasia (New York, N.Y.)|February 10, 2019
Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem CellsRobert C Fisher, Kishan Bellamkonda, L Alex Molina, et al.
NPJ Precision Oncology|July 17, 2024
Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancerThejus T Jayakrishnan, Naseer Sangwan, Shimoli V Barot, et al.
NPJ Precision Oncology|July 2, 2025
A novel structural modeling magnitude and orientation radiomic descriptor for evaluating response to neoadjuvant therapy in rectal cancers via MRICharlems Alvarez-Jimenez, Jacob T Antunes, Thomas DeSilvio, et al.
JCO Precision Oncology|October 28, 2023
Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice SurveyLinda Rodgers-Fouche, Sanjeevani Arora, Charité Ricker, et al.
Diseases of the Colon and Rectum|September 11, 2024
What Predicts Complete Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer?Sumeyye Yilmaz, David Liska, Madison L Conces, et al.
Oncotarget|July 10, 2018
Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoidsSamaneh K Sarvestani, Steven A Signs, Veronique Lefebvre, et al.
Frontiers in Oncology|June 9, 2023
Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice surveyKathryn A Mraz, Rachel Hodan, Linda Rodgers-Fouche, et al.
Nature|June 23, 2012
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerSandra Misale, Rona Yaeger, Sebastijan Hobor, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Diseases of the Colon and Rectum|December 9, 2021
Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch SyndromeHanumant Chouhan, Mohammad Ali Abbass, Jennifer E Hrabe, et al.
Diseases of the Colon and Rectum|November 11, 2024
Is Early, Postinduction Restaging of Rectal Cancer Undergoing Total Neoadjuvant Therapy Associated With Ultimate Treatment Response?William C Chapman, Emre Gorgun, Sumeyye Yilmaz, et al.
Neoplasia (New York, N.Y.)|February 10, 2019
Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem CellsRobert C Fisher, Kishan Bellamkonda, L Alex Molina, et al.
NPJ Precision Oncology|July 17, 2024
Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancerThejus T Jayakrishnan, Naseer Sangwan, Shimoli V Barot, et al.
NPJ Precision Oncology|July 2, 2025
A novel structural modeling magnitude and orientation radiomic descriptor for evaluating response to neoadjuvant therapy in rectal cancers via MRICharlems Alvarez-Jimenez, Jacob T Antunes, Thomas DeSilvio, et al.
JCO Precision Oncology|October 28, 2023
Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice SurveyLinda Rodgers-Fouche, Sanjeevani Arora, Charité Ricker, et al.
Diseases of the Colon and Rectum|September 11, 2024
What Predicts Complete Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer?Sumeyye Yilmaz, David Liska, Madison L Conces, et al.
Oncotarget|July 10, 2018
Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoidsSamaneh K Sarvestani, Steven A Signs, Veronique Lefebvre, et al.
Frontiers in Oncology|June 9, 2023
Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice surveyKathryn A Mraz, Rachel Hodan, Linda Rodgers-Fouche, et al.
Nature|June 23, 2012
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerSandra Misale, Rona Yaeger, Sebastijan Hobor, et al.
Pageof 17